(Q52559082)

3 May 2018

review article

1 reference

title

[The blood-brain barrier should not be underestimated in neuro-oncology] (English)

1 reference

3 May 2018

1 reference

Fortin D

1

1 reference

3 May 2018

publication date

1 May 2004

1 reference

3 May 2018

published in

Revue neurologique

1 reference

3 May 2018

volume

160

1 reference

3 May 2018

issue

5 Pt 1

1 reference

3 May 2018

page(s)

523-532

1 reference

3 May 2018

Long-term survival in primary CNS lymphoma

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2804%2970981-9

7 January 2021

Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2804%2970981-9

7 January 2021

Quantification of early blood-brain barrier disruption by in situ brain perfusion technique

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2804%2970981-9

7 January 2021

Osmotic opening of tight junctions in cerebral endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2804%2970981-9

7 January 2021

Successful chemotherapy for recurrent malignant oligodendroglioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2804%2970981-9

7 January 2021

Intra-arterial carboplatin chemotherapy for brain tumors: a dose escalation study based on cerebral blood flow.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2804%2970981-9

7 January 2021

Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2804%2970981-9

7 January 2021

Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2804%2970981-9

7 January 2021

Hyperosmotic arabinose solutions open the tight junctions between brain capillary endothelial cells in tissue culture

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2804%2970981-9

7 January 2021

Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2804%2970981-9

7 January 2021

A blood-brain barrier disruption model eliminating the hemodynamic effect of ketamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2804%2970981-9

7 January 2021

Oligodendroglioma: an appraisal of recent data pertaining to diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2804%2970981-9

7 January 2021

Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2804%2970981-9

7 January 2021

Association of total dose intensity of chemotherapy in primary central nervous system lymphoma (human non-acquired immunodeficiency syndrome) and survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2804%2970981-9

7 January 2021

Chemotherapeutic dose intensification for treatment of malignant brain tumors: recent developments and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2804%2970981-9

7 January 2021

Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2804%2970981-9

7 January 2021

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2804%2970981-9

7 January 2021

Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2804%2970981-9

7 January 2021

Drug delivery to the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2804%2970981-9

7 January 2021

Targeting neurotherapeutic agents through the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2804%2970981-9

7 January 2021

Testing of a hypothesis for osmotic opening of the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2804%2970981-9

7 January 2021

Intravascular streaming during carotid artery infusions. Demonstration in humans and reduction using diastole-phased pulsatile administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2804%2970981-9

7 January 2021

Isolation and characterization of human malignant glioma cells from histologically normal brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2804%2970981-9

7 January 2021

A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2804%2970981-9

7 January 2021

Enhanced delivery of boronophenylalanine for neutron capture therapy by means of intracarotid injection and blood-brain barrier disruption.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2804%2970981-9

7 January 2021

Intravenous carboplatin for recurrent malignant glioma: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2804%2970981-9

7 January 2021

Cellular and molecular neurosurgery: pathways from concept to reality--part I: target disorders and concept approaches to gene therapy of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2804%2970981-9

7 January 2021

10.1016/S0035-3787(04)70981-9

Identifiers

DOI

1 reference

3 May 2018

PubMed ID

15269669

1 reference

3 May 2018